期刊
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH
卷 23, 期 2, 页码 189-203出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/10286020.2019.1711066
关键词
Aloin; TGFBIp; sepsis; severe inflammation; HUVEC
Aloin can reduce severe inflammatory responses mediated by the extracellular matrix protein TGFBIp, making it a potential therapeutic agent for various vascular inflammatory diseases.
Aloin is the major anthraquinone glycoside obtained from the Aloe species. Transforming growth factor beta-induced protein (TGFBIp) is an extracellular matrix protein and released by primary human umbilical vein endothelial cells (HUVECs) and functions as a mediator of experimental sepsis. We hypothesized that aloin could reduce TGFBIp-mediated severe inflammatory responses in HUVECs and mice. Aloin effectively inhibited lipopolysaccharide (LPS)-induced release of TGFBIp and suppressed TGFBIp-mediated septic responses. Aloin suppressed TGFBIp-induced sepsis lethality and pulmonary injury. Therefore, aloin is a potential therapeutic agent for various severe vascular inflammatory diseases, with inhibition of the TGFBIp signaling pathway as the mechanism of action.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据